Gossamer Bio, Inc. (GOSS)
0.2089
+0.02
(+8.41%)
USD |
NASDAQ |
May 19, 11:17
Gossamer Bio Research and Development Expense (Quarterly) : 43.07M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 28.44M |
| Gilead Sciences, Inc. | 1.354B |
| Ironwood Pharmaceuticals, Inc. | 21.50M |
| REGENXBIO, Inc. | 53.48M |
| CytomX Therapeutics, Inc. | 19.02M |